Obesity is a chronic inflammatory state and adipose tissue serves as a source of inflammatory mediators. This study compared plasma levels of the proinflammatory cytokines interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) in 20 morbidly obese patients (group O) undergoing laparoscopic Roux-en-Y gastric bypass surgery and in 20 non-obese control patients (group C) undergoing laparascopic gastrectomy. Blood was sampled preoperatively and at 3 and 24 h postoperatively. Postoperative IL-6 levels increased significantly in both groups, but were significantly lower in group O than in group C. Age- and anaesthetic time-adjusted IL-6 levels showed a significant increase at 24 h postoperatively compared with preoperative values in both groups; changes were significantly greater in group C. TNF-α levels did not change significantly over time, but were significantly lower in group O at 3 h postoperatively compared with group C. In conclusion, postoperative changes in IL-6 and TNF-α levels in morbidly obese patients were lower than in non-obese patients. Adipose tissue appears not to contribute to the acute postoperative inflammatory response.
StrohackerKMcFarlinBK: Influence of obesity, physical inactivity, and weight cycling on chronic inflammation. Front Biosci (Elite Ed)2010; 2: 98–104.
2.
HotamisligilGSShargillNSSpiegelmanBM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science1993; 259: 87–91.
3.
ShoelsonSEHerreroLNaazA: Obesity, inflammation, and insulin resistance. Gastroenterology2007; 132: 2169–2180.
4.
WangZNakayamaT: Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm2010; 2010: 535918.
PouKMMassaroJMHoffmannU: Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation2007; 116: 1234–1241.
7.
HotamisligilGSArnerPCaroJF: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest1995; 95: 2409–2415.
8.
CiftciTUKokturkOBukanN: The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine2004; 28: 87–91.
9.
ForsytheLKWallaceJMLivingstoneMB: Obesity and inflammation: the effects of weight loss. Nutr Res Rev2008; 21: 117–133.
10.
SwarbrickMMStanhopeKLSmithIT Austrheim: Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia2008; 51: 1901–1911.
11.
MoschenARMolnarCGeigerS: Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression. Gut2010; 59: 1259–1264.
12.
ZiccardiPNappoFGiuglianoG: Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation2002; 105: 804–809.
13.
MonteiroRAzevedoI: Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm2010; 2010: 289645.
14.
GutierrezDAPuglisiMJHastyAH: Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia. Curr Diab Rep2009; 9: 26–32.
15.
LinECalvanoSELowrySF: Inflammatory cytokines and cell response in surgery. Surgery2000; 127: 117–126.
16.
BaumannHGauldieJ: The acute phase response. Immunol Today1994; 15: 74–80.
17.
ChoileainN NiRedmondHP: Cell response to surgery. Arch Surg2006; 141: 1132–1140.
18.
MengerMDVollmarB: Surgical trauma: hyperinflammation versus immuno-suppression?Langenbecks Arch Surg2004; 389: 475–484.
19.
DesboroughJP: The stress response to trauma and surgery. Br J Anaesth2000; 85: 109–117.
20.
Mohamed-AliVGoodrickSRaweshA: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab1997; 82: 4196–4200.
21.
SoláEJoverARuizA López: Parameters of inflammation in morbid obesity: lack of effect of moderate weight loss. Obes Surg2009; 19: 571–576.
22.
BusettoLBassettoFZocchiM: The effects of the surgical removal of subcutaneous adipose tissue on energy expenditure and adipocytokine concentrations in obese women. Nutr Metab Cardiovasc Dis2008; 18: 112–120.
23.
KhaodhiarLLingPRBlackburnGL: Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. JPEN J Parenter Enteral Nutr2004; 28: 410–415.
24.
LeeHKimDLeeS: Initial evaluation of laparoscopic Roux-en-Y gastric bypass and adjustable banding in Korea: A single institution study. Obes Surg2010; 20: 1096–1101.
25.
DoupisJRahangdaleSGnardellisC: Effects of diabetes and obesity on vascular reactivity, inflammatory cytokines, and growth factors. Obesity (Silver Spring)2011; 19: 729–735.
26.
IkeguchiMHatadaTYamamotoM: Serum interleukin-6 and–10 levels in patients with gastric cancer. Gastric Cancer2009; 12: 95–100.
27.
KuchtaKF: Pathophysiologic changes of obesity. Anesthesiol Clin North America2005; 23: 421–429.
28.
FedericoAD'AiutoEBorrielloF: Fat: A matter of disturbance for the immune system. World J Gastroenterol2010; 16: 4762–4772.
29.
FainJN: Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: A review. Mediators Inflamm2010; 2010: 513948.
30.
AraiYTakayamaMAbeY: Adipokines and aging. J Atheroscler Thromb2011; 18: 545–550.
31.
EliaMKurpadA: What is the blood flow to resting human muscle?Clin Sci (Lond)1993; 84: 559–563.
32.
BülowJAstrupAChristensenNJ: Blood flow in skin, subcutaneous adipose tissue and skeletal muscle in the forearm of normal man during an oral glucose load. Acta Physiol Scand1987; 130: 657–661.
33.
PasaricaMSeredaORRedmanLM: Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes2009; 58: 718–725.
MontalbánCDel MoralIGarcía UnzuetaMT: Perioperative response of leptin and the tumor necrosis factor alpha system in morbidly obese patients. Influence of cortisol inhibition by etomidate. Acta Anaesthesiol Scand2001; 45: 207–212.
36.
NijhuisJRensenSSSlaatsY: Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity (Silver Spring)2009; 17: 2014–2018.
37.
NeliganPJWilliamsN: Nonsurgical and surgical treatment of obesity. Anesthesiol Clin North America2005; 23: 501–523.
38.
TziomalosKDimitroulaHVKatsikiN: Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients. Mediators Inflamm2010; 2010: 364957.
39.
LaimerMEbenbichlerCFKaserS: Markers of chronic inflammation and obesity: A prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord2002; 26: 659–662.
40.
FismanEZTenenbaumA: The ubiquitous interleukin-6: A time for reappraisal. Cardiovasc Diabetol2010; 9: 62.
